Clinical trial
A Randomized Controlled Trial of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)
NCT05176756 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 14, 2022
- Completion date
- February 18, 2025
- Enrollment
- 150 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, cardiovascular diseases, physical inactivity, prostate cancer